Form 4: Bicycle Therapeutics Executive Sells Shares to Cover Tax Obligations

Michael Charles Ferguson Hannay, Chief Product & Supply Chain Officer of Bicycle Therapeutics PLC, sold shares to cover tax withholding obligations related to vested RSUs.

Summary

• On October 3, 2024, Michael Charles Ferguson Hannay, the Chief Product & Supply Chain Officer of Bicycle Therapeutics PLC, sold 247 ordinary shares.
• The sale was executed to cover statutory tax withholding obligations related to the vesting and settlement of Restricted Stock Units (RSUs).
• The shares were sold at a weighted average price of $22.26, with individual transactions ranging from $21.91 to $22.56.
• Following the transaction, Hannay directly owns 22,398 ordinary shares of Bicycle Therapeutics PLC.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The sale is related to tax obligations, not necessarily a reflection of the officer's view on the company's prospects. The officer still holds a significant number of shares.

Industry Context

Insider sales, particularly those related to covering tax obligations on vested equity, are common and generally don't signal a negative outlook on the company. Investors often look at the overall trend of insider transactions to gauge sentiment.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact given the reason for the sale.

Key Dates